PA8533401A1 - Inhibidores de la proteasa hidroxietilamina del vih - Google Patents
Inhibidores de la proteasa hidroxietilamina del vihInfo
- Publication number
- PA8533401A1 PA8533401A1 PA20018533401A PA8533401A PA8533401A1 PA 8533401 A1 PA8533401 A1 PA 8533401A1 PA 20018533401 A PA20018533401 A PA 20018533401A PA 8533401 A PA8533401 A PA 8533401A PA 8533401 A1 PA8533401 A1 PA 8533401A1
- Authority
- PA
- Panama
- Prior art keywords
- rent
- carbon
- aril
- heterociclyl
- heterociclil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REVELAN LOS COMPUESTOS DE LA FORMULA GENERAL I; Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS EN DONDE R1 ES H, HIDROXILO o NHR2 EN DONDE R2 ES H, ALQUILO, ALQUENILO, ALQUINILO, ARILALQUILO, HETEROCICLILALQUILO, CICLOALQUILO, ALQUIL CARBONILO, CICLOALQUIL CARBONILO, ARIL CARBONILO, HETEROCICLIL CARBONILO, ARIL ALQUIL CARBONILO, HETEROCICLIL ALQUIL CARBONILO, ALQUIL OXI CARBONILO, ARIL ALQUIL OXI CARBONILO, HETEROCICLIL ALQUIL OXI CARBONILO, ARILO, HETEROCICLILO, SULFONILO, AQUIL SULFONILO, ARIL SULFONILO, HETEROCICLIL SULFONILO o UN GRUPO DE FORMULA; EN DONDE X ES O ó S y R7 y R8 INDEPENDIENTEMENTE SON H, ALQUILO, ARILO, HETEROCICLILO, ARIL ALQUILO, HETEROCICLIL ALQUILO o R7 y R8 JUNTO CON EL ATOMO DE NITROGENO AL QUE ESTAN UNIDOS FORMAN UN ANILLO SATURADO QUE OPCIONALMENTE CONTIENEN ADEMAS UN HETEROATOMO; o UN GRUPO EN DONDE CUANDO N=O, Y REPRESENTA O ó S y R10 ES H, ALQUILO, ARIL ALQUILO, HETEROCICLIL ALQUILO, ARILO, HETEROCICLILO o CUANDO N=1, Y REPRESENTA N, R9 ES H O ALQUILO Y R10 H, ALQUILO, ARIL ALQUILO, HETEROCICLIL ALQUILO. ARILO HETEROCICLILO o R9 y R10 JUNTO CON EL HETEROATOMO AL QUE ESTAN UNIDOS FORMAN UN HETEROCICLO, R11 y R12 INDEPENDIENTEMENTE SON H o ALQUILO o R11 y R12 JUNTO CON EL ATOMO DE CARBONO AL QUE ESTAN UNIDOS FORMAN UN CICLO, R3, R4 INDEPENDIENTEMENTE SON ALQUILO O JUNTO CON EL ATOMO DE CARBONO AL QUE ESTAN UNIDOS FORMAN UN CARBOCICLO, R5 ES ALQUILO, ARIL ALQUILO, HETEROCICLIL ALQUILO o R4 y R5 JUNTO CON EL ATOMO DE CARBONO Y AZUFRE AL QUE ESTAN UNIDOS FORMAN UN HETEROCICLO y R6 ES ALQUILO, ARIL ALQUILO, HETEROCICLIL ALQUILO, ALQUIL OXI ALQUILO, HIDROXI ALQUILO, AMINO ALQUILO, FLUORO ALQUILO y R13 ES H o EL RESIDUO DE UN ESTER INORGANICO U ORGANICO y R15 ES ARILO, CON LA EXCEPCION QUE, SI R3, R4 y R5 SON METILO, R6 ES TERCBUTILO, R13 ES H y SI R15 ES FENILO R2 NO ES BENCIL OXICARBONILO NI 2-QUINOLINA CARBONILO. LOS COMPUESTOS DE FORMULA I SON POTENTES INHIBIDORES DE LA VIH ASPARTIL PROTEASA Y SE PUEDEN USAR EN EL TRATAMIENTO DE ENFERMEDADES RELACIONADAS CON VIH
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0028483.6A GB0028483D0 (en) | 2000-11-22 | 2000-11-22 | Hydroxyethylamine HIV protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8533401A1 true PA8533401A1 (es) | 2002-10-31 |
Family
ID=9903670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20018533401A PA8533401A1 (es) | 2000-11-22 | 2001-11-21 | Inhibidores de la proteasa hidroxietilamina del vih |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6472404B1 (es) |
| EP (1) | EP1339692A1 (es) |
| JP (1) | JP2004520283A (es) |
| KR (1) | KR20030060953A (es) |
| CN (1) | CN1476436A (es) |
| AR (1) | AR031763A1 (es) |
| AU (2) | AU2954602A (es) |
| BG (1) | BG107839A (es) |
| BR (1) | BR0115566A (es) |
| CA (1) | CA2428459A1 (es) |
| CZ (1) | CZ20031667A3 (es) |
| EC (1) | ECSP034618A (es) |
| GB (1) | GB0028483D0 (es) |
| GT (1) | GT200100233A (es) |
| HU (1) | HUP0303007A2 (es) |
| IL (1) | IL155573A0 (es) |
| MA (1) | MA26966A1 (es) |
| MX (1) | MXPA03004534A (es) |
| NO (1) | NO20032290D0 (es) |
| NZ (1) | NZ525550A (es) |
| PA (1) | PA8533401A1 (es) |
| PE (1) | PE20020610A1 (es) |
| PL (1) | PL366704A1 (es) |
| RU (1) | RU2265016C2 (es) |
| SK (1) | SK7602003A3 (es) |
| UY (1) | UY27033A1 (es) |
| WO (1) | WO2002042277A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101014572B (zh) * | 2004-09-15 | 2011-07-06 | 盐野义制药株式会社 | 具有hiv整合酶抑制活性的氨基甲酰基吡啶酮衍生物 |
| UA87884C2 (uk) * | 2004-12-03 | 2009-08-25 | Мерк Энд Ко., Инк. | Безводна кристалічна калієва сіль інгібітора віл-інтегрази |
| MY161992A (en) * | 2008-03-26 | 2017-05-31 | Daiichi Sankyo Co Ltd | Novel tetrahydroisoquinoline derivative |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8927913D0 (en) | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
| MX9308016A (es) * | 1992-12-22 | 1994-08-31 | Lilly Co Eli | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. |
-
2000
- 2000-11-22 GB GBGB0028483.6A patent/GB0028483D0/en not_active Ceased
-
2001
- 2001-11-12 AU AU2954602A patent/AU2954602A/xx active Pending
- 2001-11-12 NZ NZ525550A patent/NZ525550A/en unknown
- 2001-11-12 JP JP2002544412A patent/JP2004520283A/ja active Pending
- 2001-11-12 AU AU2002229546A patent/AU2002229546B2/en not_active Ceased
- 2001-11-12 BR BR0115566-0A patent/BR0115566A/pt not_active IP Right Cessation
- 2001-11-12 CN CNA018192890A patent/CN1476436A/zh active Pending
- 2001-11-12 WO PCT/EP2001/013068 patent/WO2002042277A1/en active IP Right Grant
- 2001-11-12 HU HU0303007A patent/HUP0303007A2/hu unknown
- 2001-11-12 SK SK760-2003A patent/SK7602003A3/sk unknown
- 2001-11-12 EP EP01990405A patent/EP1339692A1/en not_active Withdrawn
- 2001-11-12 RU RU2003117468/04A patent/RU2265016C2/ru not_active IP Right Cessation
- 2001-11-12 KR KR10-2003-7006907A patent/KR20030060953A/ko not_active Application Discontinuation
- 2001-11-12 CZ CZ20031667A patent/CZ20031667A3/cs unknown
- 2001-11-12 IL IL15557301A patent/IL155573A0/xx unknown
- 2001-11-12 CA CA002428459A patent/CA2428459A1/en not_active Abandoned
- 2001-11-12 PL PL01366704A patent/PL366704A1/xx not_active Application Discontinuation
- 2001-11-12 MX MXPA03004534A patent/MXPA03004534A/es active IP Right Grant
- 2001-11-20 US US09/999,082 patent/US6472404B1/en not_active Expired - Fee Related
- 2001-11-21 GT GT200100233A patent/GT200100233A/es unknown
- 2001-11-21 AR ARP010105431A patent/AR031763A1/es unknown
- 2001-11-21 UY UY27033A patent/UY27033A1/es not_active Application Discontinuation
- 2001-11-21 PA PA20018533401A patent/PA8533401A1/es unknown
- 2001-11-22 PE PE2001001170A patent/PE20020610A1/es not_active Application Discontinuation
-
2003
- 2003-05-21 NO NO20032290A patent/NO20032290D0/no unknown
- 2003-05-21 EC EC2003004618A patent/ECSP034618A/es unknown
- 2003-05-22 BG BG107839A patent/BG107839A/bg unknown
- 2003-05-22 MA MA27172A patent/MA26966A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20032290L (no) | 2003-05-21 |
| BG107839A (bg) | 2004-06-30 |
| NO20032290D0 (no) | 2003-05-21 |
| RU2003117468A (ru) | 2005-01-27 |
| BR0115566A (pt) | 2003-09-30 |
| MXPA03004534A (es) | 2003-09-10 |
| RU2265016C2 (ru) | 2005-11-27 |
| GT200100233A (es) | 2002-07-04 |
| EP1339692A1 (en) | 2003-09-03 |
| AR031763A1 (es) | 2003-10-01 |
| CZ20031667A3 (cs) | 2004-01-14 |
| WO2002042277A1 (en) | 2002-05-30 |
| CA2428459A1 (en) | 2002-05-30 |
| SK7602003A3 (en) | 2004-01-08 |
| GB0028483D0 (en) | 2001-01-10 |
| HUP0303007A2 (hu) | 2003-12-29 |
| MA26966A1 (fr) | 2004-12-20 |
| KR20030060953A (ko) | 2003-07-16 |
| AU2954602A (en) | 2002-06-03 |
| PE20020610A1 (es) | 2002-07-13 |
| ECSP034618A (es) | 2003-06-25 |
| JP2004520283A (ja) | 2004-07-08 |
| CN1476436A (zh) | 2004-02-18 |
| PL366704A1 (en) | 2005-02-07 |
| US6472404B1 (en) | 2002-10-29 |
| NZ525550A (en) | 2004-11-26 |
| IL155573A0 (en) | 2003-11-23 |
| AU2002229546B2 (en) | 2006-05-04 |
| UY27033A1 (es) | 2002-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8539401A1 (es) | Quinazolinas como inhibidores de mmp-13 | |
| UY26957A1 (es) | Nuevos agentes anticolinérgicos que se pueden emplear como medicamentos así como procedimiento para su preparación | |
| UY26958A1 (es) | Nuevos agentes anticolinérgicos que se pueden emplear como medicamentos así como procedimiento para su preparación | |
| PE20040479A1 (es) | Inhibidores de proteasa del vih y composiciones que los contienen | |
| CO5130016A1 (es) | Derivados de dihidrobenzodioxina carboxamida y cetona | |
| GT200100174A (es) | Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados. | |
| HUP0400456A2 (hu) | Hepatitis C vírus N-ciklikus P2 csoportokat tartalmazó makrociklusos NS3-szerin proteáz inhibitorai és ezeket tartalmazó gyógyszerkészítmények | |
| EA200400986A1 (ru) | Гетероциклические трипептиды в качестве ингибиторов вируса гепатита c | |
| PE20020474A1 (es) | Compuestos peptidomimeticos como inhibidores de la serina proteasa ns3 del virus de hepatitis c | |
| NZ506574A (en) | Cyclic amino derivative having a sulphinyl, sulphonyl or disulphanyl group useful in the treatment of thrombosis or embolism | |
| EA200100971A1 (ru) | Новые соединения и композиции в качестве ингибиторов протеазы | |
| ECSP055684A (es) | Antagonistas del receptor opiode | |
| CO4960641A1 (es) | Derivados de piperidina 1,4-disustituida conteniendo fluor | |
| EA200400987A1 (ru) | Трипептиды, несущие простой гидроксипролиновый эфир замещённого хинолина, предназначенные для ингибирования протеазы ns3 (гепатит c) | |
| PE46497A1 (es) | ANTAGONISTAS a1-ADRENOCEPTORES, SUS EMPLEOS COMO AGENTES TERAPEUTICOS Y LOS METODOS DE SU PREPARACION | |
| MX9300988A (es) | Agentes antineoplasticos de quinobenzoxazina, quinobenzotiazina y pirido-acridina y composicion farmaceutica que los contiene. | |
| BRPI0312882B8 (pt) | derivados de pleuromutilina e composição farmacêutica | |
| PE107798A1 (es) | Inhibidores espirociclicos de la metaloproteasa | |
| AR024918A1 (es) | Derivados de ciclobuteno, su preparacion y sus usos terapeuticos. | |
| DK1948627T3 (da) | Nye duale peptidaseinhibitorer som prolægemidler til terapi af inflammatoriske og andre sygdomme | |
| UY25211A1 (es) | Inhibidores de isoquinolinilguanidina uroquinasa | |
| PA8533401A1 (es) | Inhibidores de la proteasa hidroxietilamina del vih | |
| PE20040750A1 (es) | Derivados de n-(1-acetilpiperidin-4-il)-4-benzidril-2-isopropilpiperazin-1-carboxamida como inhibidores de 17beta-hidroxiesteroide deshidrogenasa de tipo 3 | |
| DE3177205D1 (de) | Industrielle verbindungen anwendbar als zwischenprodukte in der herstellung von in stellung 2 substituierten 4-hydroxy 3-quinolincarboxamid-derivaten und die herstellung von diesen zwischenprodukten. | |
| ES2033574B1 (es) | Un metodo para la preparacion de derivados de furo(3,4-c) piridina en una forma no racemica. |